← All organizations

Meiji Seika Pharma Co., Ltd.

For profitWebsite ↗

Also known as: Meiji Co., Ltd. | Meiji Pharma Spain S.A. | Meiji Pharma USA Inc. | Meiji Seika Pharma Co., Ltd.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Sep 22, 2023

Timeline

1910s

Oct 9, 1916
Meiji Seika Pharma Co., Ltd.— Founded

Drugs by trial phase (17 distinct, 17 trials)

Phase 4 (1 own, 0 via acquisition)

cefditoren

Phase 3 (8 own, 0 via acquisition)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (4 own, 0 via acquisition)

Other trials (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (24)

NCT05905055Lead sponsorPhase 3Sep 22, 2023
NCT05887908Lead sponsorPhase 3May 23, 2023
NCT05268016Lead sponsorPhase 2Mar 24, 2022
NCT04785326CollaboratorPhase 3Apr 28, 2021
NCT04709172Lead sponsorPhase 4Jan 5, 2021
NCT03313830CollaboratorN/AOct 7, 2017
NCT02927353Lead sponsorPhase 1Aug 1, 2016
NCT02927353Study directorPhase 1Aug 1, 2016
NCT02459158Study directorPhase 1Sep 1, 2015
NCT02459158Lead sponsorPhase 1Sep 1, 2015
NCT02134834Study chairPhase 1May 1, 2014
NCT02134834Lead sponsorPhase 1May 1, 2014
NCT02100917Lead sponsorPhase 1Jan 1, 2014
NCT02022215Lead sponsorPhase 2Dec 19, 2013
NCT02022215Study directorPhase 2Dec 19, 2013

Details

Founded: Tokyo, JP Oct 9, 1916
Last known activity: Sep 22, 2023